Newsfeeds - Spark Newswire

2 minute read

News

TherapeuticsMD Secures $15M Equity Investment From Rubric Capital

Today, 9:30 PM

TherapeuticsMD, Inc. (NASDAQ:TXMD), (“TherapeuticsMD” or the “Company”) an innovative, leading women’s healthcare company, announced today that it has received a $15 million private

TXMD

7 minute read

This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:30 PM

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.

AMPS

2 minute read

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 9:30 PM

ARDS

1 minute read

HC Wainwright Rating & Price Target On TherapeuticsMD Under Review On ‘Unclear Path’

By Vandana Singh

Today, 9:30 PM

The merger agreement between EW Partners and TherapeuticsMD Inc (NASDAQ:TXMD) was terminated, with EW Partners not acquiring the majority of shares…

TXMD

1 minute read

News

TherapeuticsMD Granted European Patented #EP2861072 Titled “NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES (FOR ESTROGEN AND PROGESTERONE)”

By Benzinga Newsdesk

Today, 9:30 PM

https://register.epo.org/application?number=EP13806855

TXMD

5 minute read

Twitter Shares Surge Around 8%, Here’s 66 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:30 PM

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

ABEV

2 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 9:30 PM

AGTC

4 minute read

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 9:30 PM

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

ACON